Bone. 2020 Dec 2020
Novel therapeutic approaches for the treatment of achondroplasia.
Publish at 18.11.2019
Genetic disorders of the skeletal system may affect bone and/or cartilage formation from early embryo-fetal development up to childhood. Skeletal development is a temporally-regulated non-linear process orchestrated by a complex genetic network that proceeds via two distinct ossification mechanisms, namely membranous and endochondral. An impairment of this process is responsible for a group of rare and often severe disorders: the osteochondrodysplasia.
Our research aims to contribute to the understanding of the ossification process by:
chef d'équipe
chef d'équipe
Postdoctoral fellow
Chargée de Recherche Inserm
Research Engineer
Postdoctoral fellow
Ingénieur d'étude
Post-Doctorante
Ingénieur d'étude
Doctorante
Study engineer
Doctorante
Ingénieur d'étude
Doctorante
Doctorantes en sciences médicales
Doctorante
Post Doctorante
Master2
Ingénieur d'étude
CCA AHU
PU PH
Bone. 2020 Dec 2020
Novel therapeutic approaches for the treatment of achondroplasia.
Ther Adv Endocrinol Metab. 2020
J. Bone Miner. Res. 2020
Fgfr3 Is a Positive Regulator of Osteoblast Expansion and Differentiation Dur...
J. Bone Miner. Res. 2020
Homozygous Loss-of-Function Mutations in CCDC134 Are Responsible for a Severe...
Eur J Hum Genet 2018
Expanding the phenotypic spectrum of variants in PDE4D/PRKAR1A: from acrodyso...
Neurochirurgie 2019
Hum. Mol. Genet. 2018
Constitutively-active FGFR3 disrupts primary cilium length and IFT20 traffick...
Dev. Dyn. 2017
Am J Hum Genet 2014
Am J Hum Genet 2009
Am J Hum Genet 2013
WDR34 mutations that cause short-rib polydactyly syndrome type III/severe asp...